- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/56 - Nitrogen atoms
Patent holdings for IPC class C07D 211/56
Total number of patents in this class: 325
10-year publication summary
|
32
|
26
|
18
|
26
|
18
|
20
|
12
|
16
|
9
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2718 |
20 |
| ChemoCentryx, Inc. | 370 |
8 |
| Cytokinetics, Inc. | 256 |
7 |
| Bristol-myers Squibb Company | 4789 |
6 |
| Sumitomo Chemical Company, Limited | 9015 |
6 |
| Amicus Therapeutics, Inc. | 352 |
6 |
| Araxes Pharma LLC | 91 |
6 |
| Mission Therapeutics Limited | 79 |
6 |
| Chen, XI | 8 |
6 |
| Piazza, Gary A | 7 |
6 |
| Boyd, Michael R. | 7 |
6 |
| Keeton, Adam B. | 7 |
6 |
| Janssen Pharmaceutica N.V. | 3213 |
5 |
| Oryzon Genomics S.A. | 103 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
5 |
| Unichem Laboratories Limited | 92 |
5 |
| Sanofi | 4274 |
4 |
| Rappta Therapeutics Oy | 9 |
4 |
| Centre National de La Recherche Scientifique | 10914 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 774 |
3 |
| Other owners | 202 |